PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
In Poland there are still nearly 20 million individuals with hypercholesterolaemia, most of them are unaware of their condition; that is also why only ca. 5% of patients with familial hypercholesterolaemia have been diagnosed; that is why other rare cholesterol metabolism disorders are so rarely dia...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2021-11-01
|
| Series: | Archives of Medical Science |
| Subjects: | |
| Online Access: | https://www.archivesofmedicalscience.com/PoLA-CFPiP-PCS-PSLD-PSD-PSH-guidelines-on-diagnosis-and-therapy-of-lipid-disorders,141941,0,2.html |
| _version_ | 1811181182543462400 |
|---|---|
| author | Maciej Banach Paweł Burchardt Krzysztof Chlebus Piotr Dobrowolski Dariusz Dudek Krzysztof Dyrbuś Mariusz Gąsior Piotr Jankowski Jacek Jóźwiak Longina Kłosiewicz-Latoszek Irina Kowalska Maciej Małecki Aleksander Prejbisz Michał Rakowski Jacek Rysz Bogdan Solnica Dariusz Sitkiewicz Grażyna Sygitowicz Grażyna Sypniewska Tomasz Tomasik Adam Windak Dorota Zozulińska-Ziółkiewicz Barbara Cybulska |
| author_facet | Maciej Banach Paweł Burchardt Krzysztof Chlebus Piotr Dobrowolski Dariusz Dudek Krzysztof Dyrbuś Mariusz Gąsior Piotr Jankowski Jacek Jóźwiak Longina Kłosiewicz-Latoszek Irina Kowalska Maciej Małecki Aleksander Prejbisz Michał Rakowski Jacek Rysz Bogdan Solnica Dariusz Sitkiewicz Grażyna Sygitowicz Grażyna Sypniewska Tomasz Tomasik Adam Windak Dorota Zozulińska-Ziółkiewicz Barbara Cybulska |
| author_sort | Maciej Banach |
| collection | DOAJ |
| description | In Poland there are still nearly 20 million individuals with hypercholesterolaemia, most of them are unaware of their condition; that is also why only ca. 5% of patients with familial hypercholesterolaemia have been diagnosed; that is why other rare cholesterol metabolism disorders are so rarely diagnosed in Poland. Let us hope that these guidelines, being an effect of work of experts representing 6 main scientific societies, as well as the network of PoLA lipid centers being a part of the EAS lipid centers, certification of lipidologists by PoLA, or the growing number of centers for rare diseases, with a network planned by the Ministry of Health, improvements in coordinated care for patients after myocardial infarction (KOS-Zawał), reimbursement of innovative agents, as well as introduction in Poland of an effective primary prevention program, will make improvement in relation to these unmet needs in diagnostics and treatment of lipid disorders possible. |
| first_indexed | 2024-04-11T09:15:06Z |
| format | Article |
| id | doaj.art-8f1b051de1f0463eb939fbb07cec1cef |
| institution | Directory Open Access Journal |
| issn | 1734-1922 1896-9151 |
| language | English |
| last_indexed | 2024-04-11T09:15:06Z |
| publishDate | 2021-11-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Archives of Medical Science |
| spelling | doaj.art-8f1b051de1f0463eb939fbb07cec1cef2022-12-22T04:32:23ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512021-11-011761447154710.5114/aoms/141941141941PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021Maciej Banach0https://orcid.org/0000-0001-6690-6874Paweł Burchardt1https://orcid.org/0000-0003-0353-3470Krzysztof Chlebus2https://orcid.org/0000-0001-6546-0858Piotr Dobrowolski3https://orcid.org/0000-0002-8919-1661Dariusz Dudek4https://orcid.org/0000-0001-7804-452XKrzysztof Dyrbuś5https://orcid.org/0000-0003-1323-1089Mariusz Gąsior6https://orcid.org/0000-0001-6775-1392Piotr Jankowski7https://orcid.org/0000-0001-6223-8821Jacek Jóźwiak8https://orcid.org/0000-0002-2645-7274Longina Kłosiewicz-Latoszek9https://orcid.org/0000-0003-1255-2999Irina Kowalska10https://orcid.org/0000-0001-9281-1959Maciej Małecki11https://orcid.org/0000-0002-4794-0820Aleksander Prejbisz12https://orcid.org/0000-0001-7085-0244Michał Rakowski13https://orcid.org/0000-0001-5162-6810Jacek Rysz14https://orcid.org/0000-0002-2757-6443Bogdan Solnica15https://orcid.org/0000-0002-0121-8154Dariusz Sitkiewicz16https://orcid.org/0000-0003-1767-6624Grażyna Sygitowicz17https://orcid.org/0000-0002-0057-4253Grażyna Sypniewska18https://orcid.org/0000-0001-8965-5350Tomasz Tomasik19https://orcid.org/0000-0002-9109-4174Adam Windak20https://orcid.org/0000-0001-9844-8935Dorota Zozulińska-Ziółkiewicz21https://orcid.org/0000-0003-2995-9971Barbara Cybulska22https://orcid.org/0000-0002-3745-5063Department of Preventive Cardiology and Lipidology, Medical University of Lodz, Lodz, PolandDepartment of Hypertensiology, Angiology, and Internal Medicine, K. Marcinkowski Poznan University of Medical Science, Poznan, PolandFirst Department and Chair of Cardiology, Medical University of Gdansk, Gdansk, PolandDepartment of Hypertension, National Institute of Cardiology, Warsaw, PolandInstitute of Cardiology, Jagiellonian University Medical College, Krakow, Poland3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland; Silesian Center for Heart Diseases in Zabrze, Poland3rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland; Silesian Center for Heart Diseases in Zabrze, PolandDepartment of Internal Medicine and Geriatric Cardiology, Centre of Postgraduate Medical Education, Warsaw, PolandDepartment of Family Medicine and Public Health, Institute of Medical Sciences, Faculty of Medicine, University of Opole, Opole, PolandNational Institute of Public Health NIH – National Research Institute, Warsaw, PolandDepartment of Internal Medicine and Metabolic Diseases, Medical University of Bialystok, Bialystok, PolandDepartment and Chair of Metabolic Diseases, Jagiellonian University Medical College, Krakow, PolandDepartment of Hypertension, National Institute of Cardiology, Warsaw, PolandDepartment of Molecular Biophysics, Institute of Biophysics, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, PolandChair of Nephrology, Arterial Hypertension, and Family Medicine, Medical University of Lodz, Lodz, PolandChair of Clinical Biochemistry, Jagiellonian University Medical College, Krakow, PolandDepartment of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, Warsaw, PolandDepartment of Clinical Chemistry and Laboratory Diagnostics, Medical University of Warsaw, Warsaw, PolandDepartment of Laboratory Medicine, L. Rydygier Medical College in Bydgoszcz, Nicolaus Copernicus University in Torun, PolandChair of Family Medicine, Jagiellonian University Medical College, Krakow, PolandChair of Family Medicine, Jagiellonian University Medical College, Krakow, PolandDepartment and Chair of Internal Medicine and Diabetology, K. Marcinkowski Poznan University of Medical Sciences, Poznan, PolandNational Institute of Public Health NIH – National Research Institute, Warsaw, PolandIn Poland there are still nearly 20 million individuals with hypercholesterolaemia, most of them are unaware of their condition; that is also why only ca. 5% of patients with familial hypercholesterolaemia have been diagnosed; that is why other rare cholesterol metabolism disorders are so rarely diagnosed in Poland. Let us hope that these guidelines, being an effect of work of experts representing 6 main scientific societies, as well as the network of PoLA lipid centers being a part of the EAS lipid centers, certification of lipidologists by PoLA, or the growing number of centers for rare diseases, with a network planned by the Ministry of Health, improvements in coordinated care for patients after myocardial infarction (KOS-Zawał), reimbursement of innovative agents, as well as introduction in Poland of an effective primary prevention program, will make improvement in relation to these unmet needs in diagnostics and treatment of lipid disorders possible.https://www.archivesofmedicalscience.com/PoLA-CFPiP-PCS-PSLD-PSD-PSH-guidelines-on-diagnosis-and-therapy-of-lipid-disorders,141941,0,2.htmlguidelinesrecommendationslipid disordersatherosclerosispola |
| spellingShingle | Maciej Banach Paweł Burchardt Krzysztof Chlebus Piotr Dobrowolski Dariusz Dudek Krzysztof Dyrbuś Mariusz Gąsior Piotr Jankowski Jacek Jóźwiak Longina Kłosiewicz-Latoszek Irina Kowalska Maciej Małecki Aleksander Prejbisz Michał Rakowski Jacek Rysz Bogdan Solnica Dariusz Sitkiewicz Grażyna Sygitowicz Grażyna Sypniewska Tomasz Tomasik Adam Windak Dorota Zozulińska-Ziółkiewicz Barbara Cybulska PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 Archives of Medical Science guidelines recommendations lipid disorders atherosclerosis pola |
| title | PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 |
| title_full | PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 |
| title_fullStr | PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 |
| title_full_unstemmed | PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 |
| title_short | PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021 |
| title_sort | pola cfpip pcs psld psd psh guidelines on diagnosis and therapy of lipid disorders in poland 2021 |
| topic | guidelines recommendations lipid disorders atherosclerosis pola |
| url | https://www.archivesofmedicalscience.com/PoLA-CFPiP-PCS-PSLD-PSD-PSH-guidelines-on-diagnosis-and-therapy-of-lipid-disorders,141941,0,2.html |
| work_keys_str_mv | AT maciejbanach polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT pawełburchardt polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT krzysztofchlebus polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT piotrdobrowolski polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT dariuszdudek polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT krzysztofdyrbus polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT mariuszgasior polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT piotrjankowski polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT jacekjozwiak polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT longinakłosiewiczlatoszek polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT irinakowalska polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT maciejmałecki polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT aleksanderprejbisz polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT michałrakowski polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT jacekrysz polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT bogdansolnica polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT dariuszsitkiewicz polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT grazynasygitowicz polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT grazynasypniewska polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT tomasztomasik polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT adamwindak polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT dorotazozulinskaziołkiewicz polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 AT barbaracybulska polacfpippcspsldpsdpshguidelinesondiagnosisandtherapyoflipiddisordersinpoland2021 |